Smith & Nephew SNATS Return on Tangible Equity 2010-2025 | SNN
Current and historical return on tangible equity values for Smith & Nephew SNATS (SNN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Smith & Nephew SNATS Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2014-12-31 | $0.50B | $0.27B | 78.19% |
| 2014-09-30 | $0.50B | $0.18B | 49.88% |
| 2014-06-30 | $0.52B | $0.22B | 37.67% |
| 2014-03-31 | $0.56B | $1.90B | 31.97% |
| 2013-12-31 | $0.56B | $1.74B | 32.22% |
| 2013-09-30 | $0.54B | $1.70B | 31.53% |
| 2013-06-30 | $0.55B | $1.71B | 30.28% |
| 2013-03-31 | $0.71B | $1.76B | 37.49% |
| 2012-12-31 | $0.73B | $1.63B | 37.66% |
| 2012-09-30 | $0.73B | $2.14B | 37.39% |
| 2012-06-30 | $0.73B | $2.06B | 40.66% |
| 2012-03-31 | $0.59B | $1.92B | 35.60% |
| 2011-12-31 | $0.58B | $1.67B | 37.90% |
| 2011-09-30 | $0.62B | $1.50B | 43.64% |
| 2011-06-30 | $0.63B | $1.51B | 48.36% |
| 2011-03-31 | $0.61B | $1.46B | 53.70% |
| 2010-12-31 | $0.62B | $1.25B | 63.65% |
| 2010-09-30 | $0.56B | $0.98B | 68.14% |
| 2010-06-30 | $0.55B | $0.87B | 78.24% |
| 2010-03-31 | $0.53B | $0.77B | 90.42% |
| 2009-12-31 | $0.47B | $0.67B | 99.63% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.192B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.741B | 26.94 |
| Boston Scientific (BSX) | United States | $155.895B | 37.18 |
| Stryker (SYK) | United States | $147.123B | 29.95 |
| EssilorLuxottica (ESLOY) | France | $145.891B | 0.00 |
| Medtronic (MDT) | Ireland | $116.772B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.160B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.031B | 25.15 |
| ResMed (RMD) | United States | $42.217B | 30.19 |
| GE HealthCare Technologies (GEHC) | United States | $33.398B | 15.70 |
| Agilent Technologies (A) | United States | $33.278B | 21.69 |
| Terumo (TRUMY) | Japan | $27.302B | 32.35 |
| Koninklijke Philips (PHG) | Netherlands | $26.423B | 17.48 |
| Insulet (PODD) | United States | $23.078B | 77.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.685B | 13.17 |
| Baxter (BAX) | United States | $12.250B | 9.46 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.714B | 28.33 |
| Lantheus Holdings (LNTH) | United States | $4.023B | 10.88 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.400B | 23.79 |
| Perrigo (PRGO) | Ireland | $3.224B | 8.05 |
| Prestige Consumer Healthcare (PBH) | United States | $3.221B | 14.29 |
| ICU Medical (ICUI) | United States | $3.005B | 20.46 |
| Haemonetics (HAE) | United States | $2.601B | 11.61 |
| LeMaitre Vascular (LMAT) | United States | $2.183B | 46.82 |
| Acuren (TIC) | United States | $2.054B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.918B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.804B | 77.48 |
| AtriCure (ATRC) | United States | $1.776B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.742B | 10.97 |
| Phibro Animal Health (PAHC) | United States | $1.279B | 16.35 |
| AdaptHealth (AHCO) | United States | $1.261B | 17.92 |
| Tilray Brands (TLRY) | Canada | $1.222B | 0.00 |
| Neogen (NEOG) | United States | $1.216B | 19.31 |
| BioLife Solutions (BLFS) | United States | $1.201B | 2508.00 |
| Valneva SE (VALN) | France | $0.952B | 0.00 |
| InMode (INMD) | Israel | $0.898B | 8.31 |
| Kestra Medical Technologies (KMTS) | United States | $0.876B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.622B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.609B | 0.00 |
| SNDL (SNDL) | Canada | $0.589B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.587B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.58 |
| Surmodics (SRDX) | United States | $0.516B | 0.00 |
| Evolus (EOLS) | United States | $0.480B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.471B | 16.20 |
| CeriBell (CBLL) | United States | $0.428B | 0.00 |
| Owens & Minor (OMI) | United States | $0.392B | 3.48 |
| Sanuwave Health (SNWV) | United States | $0.354B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Omeros (OMER) | United States | $0.305B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.303B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.297B | 0.00 |
| Brainsway (BWAY) | Israel | $0.283B | 57.65 |
| Viemed Healthcare (VMD) | United States | $0.273B | 20.74 |
| High Tide (HITI) | Canada | $0.273B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.270B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.231B | 0.00 |
| Cerus (CERS) | United States | $0.230B | 0.00 |
| Quanterix (QTRX) | United States | $0.225B | 0.00 |
| Exagen (XGN) | United States | $0.220B | 0.00 |
| Organigram Global (OGI) | Canada | $0.210B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.37 |
| FitLife Brands (FTLF) | United States | $0.155B | 19.10 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.17 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Jin Medical (ZJYL) | China | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.084B | 0.00 |
| Apyx Medical (APYX) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.054B | 31.47 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Veru (VERU) | United States | $0.052B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.50 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.82 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |